hyperreact
nonspecif
challeng
consid
hallmark
asthma
defin
abnorm
respons
bronchial
airway
varieti
provoc
agent
mechan
underli
hyperreact
upper
lower
airway
known
use
nose
studi
inflammatori
respons
possibl
abnorm
investig
care
pathophysiolog
specif
airway
hyperreact
better
understood
factor
mere
constrict
bronchial
smooth
muscl
caus
narrow
free
lumen
airflow
function
differ
distinct
mucos
endorgan
reactiv
may
also
increas
reactiv
well
assess
specif
airway
hyperreact
defin
present
report
specif
mucos
endorgan
hyperreactivit
allerg
nasal
mucosa
present
certain
widespread
hypothes
role
eosinophil
increas
absorpt
permeabl
theori
disput
nose
provid
excel
opportun
studi
function
aspect
inflammatori
mucos
process
airway
surfac
nose
readili
access
wellcontrol
provoc
variou
kind
stimuli
mucos
respons
equal
well
monitor
analysi
mucos
surfac
liquid
cell
biopsi
specimen
present
low
access
tracheobronchi
airway
unknown
variabl
distribut
administ
aerosol
lavag
fluid
low
recoveri
administ
lavag
fluid
henc
result
bronchoalveolar
lavag
studi
perform
clinic
must
interpret
caution
nose
howev
integr
part
airway
mucosa
offer
easi
access
studi
pathophysiolog
event
human
mucos
airway
nasal
mucosa
show
strike
similar
structur
function
aspect
tracheobronchi
mucosa
respiratori
epithelium
basement
membran
adjac
submucosa
micro
vessel
gland
appear
locat
also
data
demonstr
nasal
tracheobronchi
mucosa
exhibit
function
similar
health
diseas
nasal
studi
may
thu
serv
illustr
also
pathophysiolog
event
lower
airway
one
import
characterist
inflammatori
airway
diseas
presenc
hyperreact
nonspecif
bronchial
hyperrespons
consid
hallmark
asthma
although
may
alway
present
may
alway
correl
inflamm
present
hyperreact
bronchii
defin
abnorm
respons
airway
express
increas
obstruct
air
flow
exposur
varieti
physic
chemic
pharmacolog
provoc
agent
mechan
underli
hyperreact
upper
lower
airway
known
suggest
abnorm
may
exist
permeabl
mucosa
smooth
muscl
tissu
compound
use
nose
studi
inflammatori
respons
mani
propos
abnorm
care
investig
pathophysiolog
specif
airway
hyperreact
better
understood
factor
mere
constrict
bronchial
smooth
muscl
caus
narrow
free
lumen
airflow
furthermor
function
differ
distinct
mucos
endorgan
reactiv
may
increas
reactiv
assess
object
specif
airway
hyperreact
defin
present
articl
specif
mucos
endorgan
hyperreact
allerg
nasal
mucosa
present
certain
hypothes
role
eosinophil
increas
absorpt
permeabl
theori
disput
allergen
crosslink
two
ige
molecul
mast
cell
basophil
membran
nasal
mucosa
immedi
allerg
reaction
initi
reaction
character
typic
symptom
sneez
nasal
blockag
secret
occur
within
minut
present
antigen
immedi
allerg
nasal
reaction
follow
prolong
allerg
inflammatori
respons
continu
symptom
individu
recurr
symptom
repeat
mucos
output
mediat
plasma
latter
reaction
term
late
nasal
reaction
howev
prolong
allerg
inflammatori
respons
function
character
increas
mucos
reactiv
rechalleng
allergen
specif
challeng
reactiv
nonspecif
stimuli
histamin
methacholin
influx
activ
inflammatori
cell
superfici
part
nasal
mucosa
previou
studi
tri
character
allergeninduc
nasal
hyperreact
investig
variou
relationship
inflammatori
cell
effect
antiinflammatori
pharmacotherapi
process
studi
perform
experiment
condit
asymptomat
patient
allerg
rhiniti
pollenfre
winter
month
studi
also
undertaken
natur
cours
hayfev
give
us
opportun
valid
previou
result
obtain
experiment
challeng
allergeninduc
hyperreact
describ
initi
connel
observ
increas
nasal
respons
rechalleng
allergen
h
initi
allergen
challeng
phenomenon
term
prime
later
studi
confirm
singl
allergen
provoc
experiment
challeng
well
exposur
natur
allergen
could
increas
nasal
mucos
reactiv
stimuli
also
shown
increas
reactiv
nose
may
increas
sensit
releas
mediat
actual
repres
exagger
mucos
output
inflammatori
mediat
furthermor
hyperreact
seem
phenomenon
exclus
relat
mucosa
sinc
demonstr
site
allerg
individu
skin
presenc
increas
nasal
respons
rechalleng
allergen
initi
provoc
seem
common
featur
thu
unselect
popul
asymptomat
patient
allerg
rhiniti
major
respond
increas
nasal
symptom
increas
level
notosyllarginin
methyl
ester
tame
esteras
nasal
lavag
fluid
compar
pollen
dose
day
howev
presenc
strength
nasal
hyperreact
could
predict
standard
skin
prick
test
relev
allergen
furthermor
extent
initi
nasal
respons
relat
presenc
size
allergeninduc
hyperreact
contrast
immedi
allerg
respons
allergeninduc
hyperreact
suscept
antiinflammatori
treatment
topic
glucocorticoid
administ
initi
challeng
continu
rechalleng
h
later
allergeninduc
hyperreact
abolish
result
demonstr
allergeninduc
hyperreact
far
sensit
glucocorticoid
treatment
immedi
allerg
respons
find
support
clinic
observ
earli
glucocorticoid
effect
follow
initi
treatment
attract
hypothesi
wide
dissemin
eosinophil
propos
respons
chang
lead
increas
airway
reactiv
hypothesi
support
result
vitro
studi
show
activ
eosinophil
capabl
releas
toxic
protein
eosinophil
cation
protein
ecp
major
basic
protein
eosinophil
deriv
neurotoxin
protein
believ
damag
epithelium
expos
underli
sensori
nerv
end
hypothesi
support
suggest
link
occurr
late
lower
airway
respons
increas
lower
airway
reactiv
local
influx
activ
eosinophil
tracheobronchi
airway
mucosa
observ
taken
evid
eosinophil
play
activ
role
genesi
airway
hyperreact
upper
airway
howev
accur
analysi
perform
repeat
cell
mediat
sampl
undertaken
control
condit
possibl
confirm
role
eosinophil
develop
hyperreact
nasal
challeng
procedur
use
studi
tissu
respons
allergen
includ
repeat
methacholin
challeng
prior
allergen
challeng
methacholin
given
topic
nasal
mucosa
induc
glandular
secretori
respons
allow
volum
induc
secret
measur
accord
techniqu
describ
borum
nasal
lavag
perform
immedi
prior
methacholin
challeng
total
rel
number
eosinophil
count
level
ecp
measur
marker
eosinophil
activ
h
allergen
challeng
increas
nasal
secretori
respons
methacholin
demonstr
timepoint
rel
number
eosinophil
found
increas
lavag
fluid
studi
correl
observ
number
eosinophil
level
ecp
fluid
suggest
harvest
cell
activ
howev
specif
relationship
could
found
number
eosinophil
glandular
secretori
respons
thu
individu
demonstr
earli
influx
eosinophil
nasal
mucosa
later
increas
glandular
secretori
reactiv
vice
versa
find
suggest
express
airway
mucos
inflamm
influx
eosinophil
secretori
hyperreact
happen
time
may
necessarili
link
use
similar
experiment
challeng
protocol
repeat
methacholin
challeng
prior
differ
dose
topic
intranas
pollen
allergen
found
weaker
dose
allergen
induc
increas
secretori
reactiv
stronger
dose
allergen
result
increas
secretori
reactiv
within
min
immedi
allerg
reaction
number
eosinophil
increas
nasal
lavag
fluid
min
challeng
determin
increas
level
ecr
observ
suggest
hyperreact
found
obligatorili
link
presenc
socal
latephas
reaction
reaction
occur
sever
hour
later
suggest
newer
gener
nonsed
antihistamin
may
possess
properti
addit
block
h
receptor
nasal
mucosa
effect
two
nonsed
antihistamin
terfenadin
cetirizin
allergeninduc
secretori
hyperreact
eosinophilia
studi
laboratori
cell
glandular
secretori
respons
calcul
h
nasal
allergen
challeng
found
antihistamin
reduc
nasal
secretori
hyperreact
compar
placebo
drug
howev
reduc
increas
number
eosinophil
h
immedi
allerg
reaction
cascad
event
follow
allergen
present
airway
mucosa
lead
increas
hyperreact
thu
seem
possibl
assum
one
sever
mediat
releas
immedi
allerg
reaction
could
respons
induct
phenomenon
shown
previous
neither
histamin
methacholin
increas
airway
reactiv
platelet
activ
factor
paf
inflammatori
mediat
suggest
respons
induc
airway
hyperreact
recruit
eosinophil
skin
atop
individu
paf
appli
topic
nasal
mucosa
found
increas
glandular
secretori
reactiv
contrast
allergen
actual
possess
weak
eosinophil
chemotact
effect
knowledg
pathophysiolog
allerg
rhiniti
base
mainli
result
achiev
laboratori
challeng
experi
recent
studi
address
whether
pathophysiolog
chang
pharmacolog
effect
achiev
also
relev
clinic
condit
diseas
seri
studi
monitor
differ
aspect
mucos
inflammatori
respons
natur
cours
allerg
rhiniti
patient
activ
season
allerg
rhiniti
found
increas
mucos
output
albumin
bradykinin
harvest
nasal
wash
express
exud
plasma
protein
activ
plasma
protein
system
format
proinflammatori
mediat
increas
number
eosinophil
ecp
also
observ
nasal
mucos
surfac
natur
diseas
chang
accompani
increas
secretori
respons
nasal
mucosa
methacholin
also
demonstr
mild
pollen
season
produc
signific
increas
actual
symptom
increas
number
activ
eosinophil
well
increas
secretori
respons
methacholin
significantli
inhibit
topic
administr
glucocorticoid
although
pollen
exposur
diminish
end
pollen
season
patient
still
pronounc
symptom
experi
nasal
complaint
time
earlier
season
respons
pollen
amount
find
suggest
presenc
natur
acquir
hyperreact
allergen
end
birchpollen
season
also
abl
demonstr
increas
vascular
exud
respons
histamin
compar
histamin
dose
symptomfre
time
outsid
season
unpublish
studi
found
increas
sensori
neural
reactiv
natur
occur
allerg
diseas
capsaicin
neurogen
compound
stimul
releas
neuropeptid
sensori
nerv
end
appli
nasal
mucosa
end
pollen
season
patient
activ
allerg
rhiniti
experienc
intens
pain
nose
pollen
season
neurogen
stimulu
may
produc
increas
secretori
respons
capsaicininduc
neurogen
inflamm
plasma
exud
occur
human
airway
even
condit
activ
allerg
rhiniti
differ
mucos
endorgan
reactiv
explain
increas
absorpt
permeabl
nasal
mucosa
late
pollen
season
patient
show
increas
respons
low
pollen
exposur
absorpt
radioact
tracer
across
nasal
mucosa
significantli
lower
found
week
prior
allerg
season
patient
asymptomat
studi
carri
natur
occur
allerg
rhiniti
demonstr
increas
mucos
exud
plasma
secretori
sensorineur
vascular
exud
hyperreact
well
increas
number
activ
mast
cell
eosinophil
reduc
absorpt
permeabl
allergeninduc
nasal
hyperreact
common
import
featur
inflammatori
process
affect
airway
mucosa
howev
underli
pathophysiolog
mechan
lead
increas
airway
reactiv
still
obscur
result
question
clearcut
link
latephas
reaction
influx
activ
eosinophil
develop
hyperreact
propos
inflammatori
mucosa
function
character
differ
specif
endorgan
hyperreact
hyperrespons
explain
increas
mucos
penetr
allergen
challeng
agent
may
rather
reflect
increas
releas
cellular
mediat
increas
sensit
specif
mucos
endorgan
